Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Twist Bioscience Corp TWST

Healthcare Biotechnology
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of... see more

Recent & Breaking News (NDAQ:TWST)

Twist Bioscience Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Twist Bioscience Corporation of Deadline in Securities Fraud Class Action Lawsuit

PR Newswire February 8, 2023

Twist Shareholder Notice

Newsfile February 8, 2023

Twist Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2023 to Discuss Your Rights - TWST

Newsfile February 8, 2023

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm's Attorneys Before Feb. 10th Deadline in Securities Fraud Class Action

Newsfile February 8, 2023

TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit

PR Newswire February 8, 2023

TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Twist Bioscience Corporation (NASDAQ: TWST)

PR Newswire February 8, 2023

FRIDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Newsfile February 8, 2023

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Twist Bioscience Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 10, 2023 - (NASDAQ: TWST)

PR Newswire February 8, 2023

TWIST BIOSCIENCE 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST

Business Wire February 7, 2023

Twist Shareholder Action Reminder

Newsfile February 7, 2023

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Twist Bioscience Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 10, 2023 - (TWST)

Newsfile February 7, 2023

TWST Important Friday Deadline: ROSEN, Leading Trial Lawyers, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - TWST

Newsfile February 7, 2023

TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit

Newsfile February 7, 2023

TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

Newsfile February 7, 2023

FRIDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Newsfile February 7, 2023

Twist Bioscience Announces Technology Early Access of Enhanced Whole Genome Sequencing Solution at AGBT

Business Wire February 7, 2023

TWST ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 10, 2023 in the Class Action Filed on Behalf of Twist Bioscience Corporation Shareholders

PR Newswire February 7, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST

PR Newswire February 7, 2023

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Twist Bioscience (TWST) Investors to Feb. 10th Deadline in Securities Fraud Class Action, Urges Investors with Losses to Contact Firm's Attorneys

Newsfile February 6, 2023

TWST FINAL DEADLINE FRIDAY: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - TWST

PR Newswire February 6, 2023